Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy
Authors:
Open Access
- 1 March 2008
- journal article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 40 (3) , 217-225
Abstract
Tyrosine kinase with immunoglobulin and epidermal growth factor homology domain-2 (Tie2) has been considered as a rational target for gene therapy in solid tumors. In order to identify a novel peptide ligand of Tie2 for targeted gene therapy, we screened a phage display peptide library and identified a candidate peptide ligand NSLSNASEFRAPY (designated GA5). Binding assays and Scatchard analysis revealed that GA5 could specifically bind to Tie2 with a dissociation constant of 2.1 × 10−8 M. In addition, we showed that GA5 was internalized into tumor cells highly expressing Tie2. In the biodistribution assay, 125I-GA5 was mainly accumulated in SPC-A1 xenograft tumors that express Tie2. In gene delivery studies, GA5-conjugated polyethylenimine vector could achieve greater transgene transduction than non-targeted vectors both in vitro and in vivo. Tumor growth inhibition was observed in SPC-A1 xenograft-bearing mice that received eight intratumoral injections of GA5-polyethylenimine/p53 complexes in 3 weeks. The difference in tumor volume between the experiment and control groups was significant (P< 0.05). Our results showed that GA5 is a potentially efficient targeting element for cancer gene or moleculartherapy.Keywords
This publication has 26 references indexed in Scilit:
- A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2Biochemical and Biophysical Research Communications, 2004
- Targeting the Tie2/Tek Receptor in AstrocytomasThe American Journal of Pathology, 2004
- In Vivo Targeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral VectorsHuman Gene Therapy, 2003
- In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vectorCancer Gene Therapy, 2002
- Tie2 vascular endothelial receptor expression and function in hepatocellular carcinomaHepatology, 2002
- Aerosol delivery of PEI–p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesisCancer Gene Therapy, 2002
- Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI– p53 complexesCancer Gene Therapy, 2001
- Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivativesCancer Gene Therapy, 2001
- Coupling of cell-binding ligands to polyethylenimine for targeted gene deliveryGene Therapy, 1997
- Radiolabelled peptidesNuclear Medicine Communications, 1995